[go: up one dir, main page]

AU2003241599A1 - Compositions and methods for the treatment of hemophilia a - Google Patents

Compositions and methods for the treatment of hemophilia a

Info

Publication number
AU2003241599A1
AU2003241599A1 AU2003241599A AU2003241599A AU2003241599A1 AU 2003241599 A1 AU2003241599 A1 AU 2003241599A1 AU 2003241599 A AU2003241599 A AU 2003241599A AU 2003241599 A AU2003241599 A AU 2003241599A AU 2003241599 A1 AU2003241599 A1 AU 2003241599A1
Authority
AU
Australia
Prior art keywords
hemophilia
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241599A
Inventor
Rodney M. Camire
Katherine A. High
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Original Assignee
Childrens Hospital of Philadelphia CHOP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital of Philadelphia CHOP filed Critical Childrens Hospital of Philadelphia CHOP
Publication of AU2003241599A1 publication Critical patent/AU2003241599A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003241599A 2002-05-22 2003-05-22 Compositions and methods for the treatment of hemophilia a Abandoned AU2003241599A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38248602P 2002-05-22 2002-05-22
US60/382,486 2002-05-22
PCT/US2003/016376 WO2003100053A1 (en) 2002-05-22 2003-05-22 Compositions and methods for the treatment of hemophilia a

Publications (1)

Publication Number Publication Date
AU2003241599A1 true AU2003241599A1 (en) 2003-12-12

Family

ID=29584417

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241599A Abandoned AU2003241599A1 (en) 2002-05-22 2003-05-22 Compositions and methods for the treatment of hemophilia a

Country Status (3)

Country Link
US (2) US7211558B2 (en)
AU (1) AU2003241599A1 (en)
WO (1) WO2003100053A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040102388A1 (en) * 2000-03-22 2004-05-27 High Katherine A. Modified blood clotting factors and methods of use
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
JP4644663B2 (en) 2003-06-03 2011-03-02 セル ジェネシス インコーポレイテッド Construction and method for enhanced expression of recombinant polypeptides from a single vector using peptide cleavage sites
JP2009528293A (en) * 2006-02-23 2009-08-06 ザ チルドレンズ ホスピタル オブ フィラデルフィア Compositions and methods for regulating hemostasis using various forms of activated factor V
ES2717902T5 (en) 2009-10-02 2022-11-29 Childrens Hospital Philadelphia Compositions and methods for improving the function of coagulation factor VIII
US20110150843A1 (en) * 2009-10-30 2011-06-23 National Institute Of Immunology Method for the therapeutic correction of hemophilia a by transplanting bone marrow cells
WO2011060371A2 (en) * 2009-11-13 2011-05-19 Puget Sound Blood Center Factor viii t cell epitope variants having reduced immunogenicity
PT2591006T (en) * 2010-07-09 2019-07-29 Bioverativ Therapeutics Inc Processable single chain molecules and polypeptides made using same
US10202595B2 (en) 2012-06-08 2019-02-12 Bioverativ Therapeutics Inc. Chimeric clotting factors
EP4079316A1 (en) 2012-06-08 2022-10-26 Bioverativ Therapeutics Inc. Procoagulant compounds
DK3889173T5 (en) 2013-02-15 2024-08-05 Bioverativ Therapeutics Inc OPTIMIZED FACTOR VIII GENE
AR101060A1 (en) * 2014-02-12 2016-11-23 Novo Nordisk As FVIII CONJUGATES
US11008561B2 (en) 2014-06-30 2021-05-18 Bioverativ Therapeutics Inc. Optimized factor IX gene
WO2016123200A1 (en) * 2015-01-30 2016-08-04 Emory University Factor viii proteins having ancestral sequences, expression vectors, and uses related thereto
AU2017214378B2 (en) 2016-02-01 2023-05-04 Bioverativ Therapeutics Inc. Optimized Factor VIII genes
TW202126284A (en) 2019-09-30 2021-07-16 美商百歐維拉提夫治療公司 Lentiviral vector formulations
KR20230074703A (en) 2020-06-24 2023-05-31 바이오버라티브 테라퓨틱스 인크. Method for removing free factor VIII from preparations of lentiviral vectors modified to express the protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171844A (en) * 1987-06-12 1992-12-15 Gist-Brocades N.W. Proteins with factor viii activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them
EP0574402B2 (en) * 1990-11-26 2012-08-01 Genetics Institute, LLC Expression of pace in host cells and methods of use thereof
DK1754718T3 (en) * 1996-04-24 2011-07-18 Univ Michigan Inactivation-resistant factor VIII

Also Published As

Publication number Publication date
WO2003100053A1 (en) 2003-12-04
US20040005670A1 (en) 2004-01-08
US7211558B2 (en) 2007-05-01
US20070166283A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
AU2003267644A1 (en) Dental compositions and methods
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003259735A1 (en) Small-mer compositions and methods of use
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003226094A1 (en) Compounds and methods
AU2003256805A1 (en) Compounds compositions and methods
AU2003217159A1 (en) Compositions and methods for the treatment of wastewater and other waste
AU2003287443A1 (en) Compositions and methods for pain reduction
AU2003271944A1 (en) Methods for making water treatment compositions and compositions thereof
AU2003241599A1 (en) Compositions and methods for the treatment of hemophilia a
AU2003299441A1 (en) Nf-hev compositions and methods of use
AU2003275268A1 (en) Hemostatic compositions and methods
AU2003296469A1 (en) Dental compositions including enzymes and methods
AU2003281687A1 (en) Photopolymerizable composition and use thereof
AU2003282722A1 (en) Therapeutic compositions
AU2002366809A1 (en) Syn3 compositions and methods
AU2003259202A1 (en) Compositions and methods for treating and preventing infection
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2003303948A1 (en) Compositions and methods for preventing infection
AU2003275069A1 (en) Compositions and methods for preventing infection
AU2003265281A1 (en) Methods and compositions for the enhancement of wound healing
AU2003275433A1 (en) Compositions and methods for treating pain
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase